傲农生物
(603363)
| 流通市值：77.80亿 | | | 总市值：94.49亿 |
| 流通股本：21.43亿 | | | 总股本：26.03亿 |
| 报告期 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 697,570,126.52 | 696,899,200.38 | 820,185,758.72 | 843,852,281.49 |
| 交易性金融资产 | 1,112,832.6 | 1,208,843.64 | 1,603,396.35 | 516,665.32 |
| 衍生金融资产 | - | 86,000 | 7,600 | - |
| 应收票据及应收账款 | 509,906,019.38 | 706,781,222.06 | 546,998,307.4 | 464,046,243.89 |
| 其中：应收票据 | 50,000 | - | - | - |
| 应收账款 | 509,856,019.38 | 706,781,222.06 | 546,998,307.4 | 464,046,243.89 |
| 应收款项融资 | 300,000 | 200,000 | 50,000 | 50,000 |
| 预付款项 | 155,474,017.9 | 137,051,566.63 | 152,712,232.93 | 175,843,120.94 |
| 其他应收款合计 | 840,059,622.77 | 898,309,345.59 | 810,813,205.59 | 758,910,284.18 |
| 应收股利 | 2,587,982.85 | 2,587,982.85 | 2,587,982.85 | 2,587,982.85 |
| 存货 | 955,400,828.99 | 887,771,099.63 | 905,898,171.16 | 834,543,287.7 |
| 一年内到期的非流动资产 | - | - | 748,843.07 | 1,007,054.67 |
| 其他流动资产 | 172,107,910.37 | 193,773,704.81 | 190,283,629.58 | 189,293,740.36 |
| 流动资产合计 | 3,331,931,358.53 | 3,522,080,982.74 | 3,429,301,144.8 | 3,268,062,678.55 |
| 非流动资产: | | | | |
| 长期应收款 | - | - | - | 1,484,832.07 |
| 长期股权投资 | 110,623,351.37 | 121,555,769.57 | 120,406,810.07 | 124,264,525.6 |
| 其他权益工具投资 | 5,749,593.85 | 4,218,892.31 | 4,416,343.97 | 4,634,335.74 |
| 其他非流动金融资产 | 16,556,640 | 37,356,640 | 37,356,640 | 37,356,640 |
| 投资性房地产 | 115,893,331.91 | 49,188,153.06 | 49,850,201.13 | 50,516,374.57 |
| 固定资产 | 3,022,063,527.31 | 3,172,510,148.63 | 3,264,431,046.72 | 3,461,713,633.88 |
| 在建工程 | 421,801,478.26 | 428,245,748.3 | 462,631,587.77 | 462,579,856.53 |
| 生产性生物资产 | 345,440,540.78 | 318,671,660.46 | 314,006,019.35 | 287,808,547.51 |
| 使用权资产 | 324,468,937.22 | 341,907,009.39 | 353,993,264.32 | 371,157,759.32 |
| 无形资产 | 315,958,304.24 | 320,198,667.16 | 327,393,564.36 | 330,358,590.62 |
| 商誉 | 337,744,304.77 | 357,209,598.98 | 357,127,069.45 | 364,426,977.57 |
| 长期待摊费用 | 167,818,000.63 | 156,471,367.16 | 151,211,774.08 | 155,099,203.55 |
| 递延所得税资产 | 142,634,087.65 | 179,466,806.16 | 161,054,622.36 | 137,955,243.2 |
| 其他非流动资产 | 83,253,280.83 | 139,063,524.21 | 137,171,708.45 | 136,118,874.72 |
| 非流动资产合计 | 5,410,005,378.82 | 5,626,063,985.39 | 5,741,050,652.03 | 5,925,475,394.88 |
| 资产总计 | 8,741,936,737.35 | 9,148,144,968.13 | 9,170,351,796.83 | 9,193,538,073.43 |
| 流动负债: | | | | |
| 短期借款 | 297,740,034.26 | 366,228,929.98 | 432,681,596.68 | 555,693,967.33 |
| 衍生金融负债 | 673,680 | 83,400 | - | 35,060 |
| 应付票据及应付账款 | 1,410,227,277.66 | 1,296,371,918.33 | 1,362,590,449.32 | 1,415,819,283.75 |
| 其中：应付票据 | 36,488,468 | 21,922,259.4 | - | - |
| 应付账款 | 1,373,738,809.66 | 1,274,449,658.93 | 1,362,590,449.32 | 1,415,819,283.75 |
| 合同负债 | 138,275,293.96 | 164,654,437.68 | 173,852,981.29 | 187,115,446.86 |
| 应付职工薪酬 | 87,986,782.6 | 74,345,493.48 | 68,825,708.14 | 70,713,179.41 |
| 应交税费 | 28,450,745.29 | 24,382,975.2 | 17,177,486.49 | 20,055,128.7 |
| 其他应付款合计 | 1,022,628,644.93 | 1,045,866,482.88 | 1,083,916,511.93 | 1,145,825,605.77 |
| 其中:应付利息 | 29,281,018.92 | 27,725,766.08 | 24,136,196.89 | 31,379,930.58 |
| 应付股利 | 1,532,000 | 4,900,000 | 5,405,777.7 | 6,585,925.69 |
| 一年内到期的非流动负债 | 579,575,063.24 | 474,293,639.19 | 453,392,603.02 | 456,927,350.47 |
| 其他流动负债 | 380,877.58 | 567,178.81 | 533,013.58 | 435,201.02 |
| 流动负债合计 | 3,565,938,399.52 | 3,446,794,455.55 | 3,592,970,350.45 | 3,852,620,223.31 |
| 非流动负债: | | | | |
| 长期借款 | 1,279,350,220.9 | 1,586,852,473.04 | 1,580,983,741.48 | 1,512,720,086.14 |
| 租赁负债 | 172,833,269.17 | 187,150,545.64 | 197,329,206.59 | 206,396,167.41 |
| 长期应付款 | - | 539,406.43 | 2,832,232.79 | 17,081,281.78 |
| 预计负债 | 31,794,885.69 | 27,574,748.6 | 61,285,106.46 | 61,308,289.13 |
| 递延收益 | 99,641,153.59 | 101,599,013.48 | 103,759,157.2 | 106,181,635.46 |
| 递延所得税负债 | 12,175,596.17 | 12,468,931.68 | 12,779,728.69 | 13,271,563.66 |
| 非流动负债合计 | 1,595,795,125.52 | 1,916,185,118.87 | 1,958,969,173.21 | 1,916,959,023.58 |
| 负债合计 | 5,161,733,525.04 | 5,362,979,574.42 | 5,551,939,523.66 | 5,769,579,246.89 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,602,961,826 | 2,602,961,826 | 2,602,961,826 | 2,602,961,826 |
| 资本公积 | 5,475,002,679.05 | 5,351,688,871.57 | 5,242,072,131.23 | 5,130,122,209.99 |
| 其他综合收益 | -48,940,364.65 | -50,474,167.35 | -50,279,816.84 | -50,064,926.23 |
| 盈余公积 | 68,356,991.56 | 68,356,991.56 | 68,356,991.56 | 68,356,991.56 |
| 未分配利润 | -4,966,907,349.52 | -4,630,595,616.79 | -4,683,727,804.49 | -4,826,223,615.59 |
| 归属于母公司股东权益合计 | 3,130,473,782.44 | 3,341,937,904.99 | 3,179,383,327.46 | 2,925,152,485.73 |
| 少数股东权益 | 449,729,429.87 | 443,227,488.72 | 439,028,945.71 | 498,806,340.81 |
| 股东权益合计 | 3,580,203,212.31 | 3,785,165,393.71 | 3,618,412,273.17 | 3,423,958,826.54 |
| 负债和股东权益合计 | 8,741,936,737.35 | 9,148,144,968.13 | 9,170,351,796.83 | 9,193,538,073.43 |
| 公告日期 | 2026-04-23 | 2025-10-28 | 2025-08-26 | 2025-04-30 |
| 审计意见(境内) | 标准无保留意见 | | | |